KYMERA

Serial Number 88203311
Registration 6852718
700

Registration Progress

Application Filed
Nov 22, 2018
Under Examination
Jan 12, 2021
Approved for Publication
Oct 8, 2019
Published for Opposition
Oct 8, 2019
Registered
Sep 20, 2022

Trademark Image

KYMERA

Basic Information

Serial Number
88203311
Registration Number
6852718
Filing Date
November 22, 2018
Registration Date
September 20, 2022
Published for Opposition
October 8, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 20, 2022
Registration
Registered
Classes
042

Rights Holder

Kymera Therapeutics, Inc.

03
Address
500 North Beacon Street, 4th Floor
Watertown, MA 02472

Ownership History

Kymera Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

Kymera Therapeutics, Inc.

Owner at Publication
03
Watertown, MA

Kymera Therapeutics, Inc.

Original Registrant
03
Watertown, MA

Legal Representation

Attorney
Lisa M. Tittemore

USPTO Deadlines

Next Deadline
1146 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-09-20)
Due Date
September 20, 2028
Grace Period Ends
March 20, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

49 events
Date Code Type Description Documents
Jun 6, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 6, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 6, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 26, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jun 26, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 26, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 26, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 26, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 26, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 20, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 20, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 13, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Aug 12, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jul 19, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 18, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 18, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jul 12, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 12, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jul 12, 2022 IUAF S USE AMENDMENT FILED Loading...
Jul 12, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 13, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 11, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 11, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 11, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 20, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 19, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 19, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 12, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 12, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 12, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 3, 2020 OP.T T OPPOSITION TERMINATED NO. 999999 Loading...
Dec 3, 2020 TMBN T TTAB RELEASE CASE TO TRADEMARKS Loading...
Nov 2, 2020 OP.D T OPPOSITION DISMISSED NO. 999999 Loading...
Nov 14, 2019 OP.I T OPPOSITION INSTITUTED NO. 999999 Loading...
Nov 7, 2019 OPPF T OPPOSITION PAPERS RECEIVED AT TTAB Loading...
Oct 8, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 8, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 18, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 5, 2019 ALIE A ASSIGNED TO LIE Loading...
Sep 3, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 24, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 23, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 23, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 26, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 26, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 26, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 25, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 12, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 26, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Research and development of therapeutic drugs for the treatment of oncology, autoimmune, immune-oncology and other related diseases; Research and development of pharmaceuticals, and research and development of technology in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Medical research for development of therapeutic modalities for treatment of diseases; Clinical studies; Preclinical and clinical development of therapeutic products
First Use Anywhere: Oct 31, 2017
First Use in Commerce: Oct 31, 2017

Classification

International Classes
042